These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30947660)

  • 21. Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression.
    Zhou C; Wang Y; Wang Y; Lei L; Ji MH; Zhou G; Xia H; Yang JJ
    Aging (Albany NY); 2021 Feb; 13(6):8706-8719. PubMed ID: 33619234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
    Shen J; Xu J; Chen B; Ma D; Chen Z; Li JC; Zhu C
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1681-1693. PubMed ID: 31175464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
    Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
    BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
    Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S
    Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
    Zheng S; Luo X; Dong C; Zheng D; Xie J; Zhuge L; Sun Y; Chen H
    Int J Cancer; 2018 Nov; 143(10):2592-2601. PubMed ID: 30152019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
    Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
    Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Zhao Y; Varn FS; Cai G; Xiao F; Amos CI; Cheng C
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):86-95. PubMed ID: 29141854
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypoxia-associated alternative splicing signature in lung adenocarcinoma.
    Xu Z; Wei J; Qin F; Sun Y; Xiang W; Yuan L; Qin J; Deng K; Zheng T; Li S
    Epigenomics; 2021 Jan; 13(1):47-63. PubMed ID: 33336585
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
    Wang G; Bie F; Qu X; Yang X; Liu S; Wang Y; Huang C; Wang K; Du J
    Sci Rep; 2018 Sep; 8(1):13221. PubMed ID: 30185829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
    Qi L; Li T; Shi G; Wang J; Li X; Zhang S; Chen L; Qin Y; Gu Y; Zhao W; Guo Z
    Mol Oncol; 2017 Nov; 11(11):1630-1645. PubMed ID: 28922552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
    Zhang H; Lu J; Yang Y; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
    Li G; Wang G; Guo Y; Li S; Zhang Y; Li J; Peng B
    World J Surg Oncol; 2020 Sep; 18(1):249. PubMed ID: 32950055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.